vitamin-b-12 has been researched along with Preleukemia* in 5 studies
2 review(s) available for vitamin-b-12 and Preleukemia
Article | Year |
---|---|
[Preleukemic states].
Topics: Adrenal Cortex Hormones; Aged; Alkaline Phosphatase; Androgens; Antineoplastic Agents; Blood Cell Count; Blood Transfusion; Chromosome Aberrations; Chromosome Disorders; Folic Acid; Humans; Leukocytes; Middle Aged; Muramidase; Myeloproliferative Disorders; Peroxidase; Preleukemia; Prognosis; Pyridoxine; Vitamin B 12 | 1982 |
[Preleukemic syndrome].
Topics: Anemia, Aplastic; Anemia, Macrocytic; Antineoplastic Agents; Bone Marrow; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Metaplasia; Preleukemia; Prognosis; Syndrome; Vitamin B 12 | 1980 |
3 other study(ies) available for vitamin-b-12 and Preleukemia
Article | Year |
---|---|
[Drug-induced anemias].
The facts known today about the occurrence and possible mechanisms of anaemias caused by medicaments are represented in a survey. In this connection toxic haemolytic anaemias, immunohaemolytic anaemias, toxic aplastic anaemias, megaloblastic anaemias, and some other, more rarely occurring types are referred to. Topics: Alcoholism; Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anemia, Megaloblastic; Anemia, Sideroblastic; Antitubercular Agents; Benzenesulfonates; Bone Marrow; Chloramphenicol; Chromosome Aberrations; Contraceptives, Oral, Hormonal; Folic Acid Antagonists; Gastrointestinal Hemorrhage; Humans; Preleukemia; Purines; Pyrimidines; Vitamin B 12 | 1980 |
Studies on hemopoietic dysplasia (the preleukemic syndrome). Clinical course and prognostic factors in 42 patients with dysplastic bone marrow.
The clinical course of 42 patients with hemopoietic dysplasia diagnosed during 1974-77 has been studied. The clinical, laboratory and morphological findings at presentation were investigated for prognostic significance. At the time of completion of the study (Aug. 1979), 38% had developed acute leukemia (median survival after diagnosis 5 months) and 45% had died of complications (bleeding and infections) due to severe cytopenia (median survival 6 months). An overall malignant course was observed in patients with low platelet count (less than 80 X 10(9)/l), bleedings and severe myeloid maturation defect in the bone marrow (greater than or equal to 30% myeloblasts and promyelocytes). Increased serum vitamin B12 and presence of myeloblasts, promyelocytes and abnormal "monocytoid' cells in the peripheral blood indicated a leukemic termination. Topics: Aged; Bone Marrow; Female; Humans; Male; Platelet Count; Preleukemia; Prognosis; Thrombocytopenia; Vitamin B 12 | 1980 |
The preleukemic syndrome: clinical and laboratory features, natural course, and management.
The clinical and laboratory features of the stages in the evolution of acute nonlymphocytic leukemia are reviewed. Based on a retrospective analysis of 34 patients who died with an acute myelomonoblastic leukemia, the "preleukemic syndrome" has been shown to display a clinical picture sufficiently specific to permit its recognition prospectively (i.e., before the development of overt leukemia). The results to date of a variety of prospective studies are reviewed, and the approach(es) to the management of these cases is considered. Topics: Adrenal Cortex Hormones; Aged; Androgens; Antimetabolites, Antineoplastic; Blood Transfusion; Bone Marrow Cells; Erythrocytes, Abnormal; Folic Acid; Granulocytes; Humans; Male; Megakaryocytes; Middle Aged; Preleukemia; Retrospective Studies; Splenectomy; Vitamin B 12 | 1976 |